Trial Profile
Prospective, Open-label Observational Survey Evaluating Patients Compliance to Administration Regimen During Low Dose Combined Oral Contraceptive Use in Everyday Praxis Data on Oral Contraceptives Compliance - DOC Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2010
Price :
$35
*
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms DOC
- Sponsors Bayer
- 18 Sep 2010 New trial record